Role of Oxidative Stress in the Suppression of Immune Responses in Peripheral Blood Mononuclear Cells Exposed to Combustible Tobacco Product Preparation

Inflammation

Volumn 40, Issue 5, 2017, Pages 1622-1630

  Arimilli, Subhashini ^a   Schmidt, Eckhardt ^b   Damratoski, Brad E ^a   Prasad, G L ^b  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b RAI Services Company   (United States)

Author keywords

cytokines; cytolysis; cytotoxicity; LPS; N acetylcysteine; PBMCs; tobacco product preparations

Indexed keywords

7 AMINODACTINOMYCIN; ACETALDEHYDE; ACETONE; ACETYLCYSTEINE; ACROLEIN; ACRYLAMIDE; AMMONIA; ANABASINE; ANATABINE; BIS(2 HYDROXYETHYL)NITROSAMINE; CIGARETTE SMOKE; COUMARIN; FORMALDEHYDE; GLUTATHIONE; INTERLEUKIN 6; INTERLEUKIN 8; MYOSMINE; NICOTINE; NITRITE; NITROSAMINE; NITROSOANABASINE; NITROSOANATABINE; NITROSONORNICOTINE; NORNICOTINE; PERFORIN; PROPIONALDEHYDE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; URETHAN; CYTOKINE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL KILLING; COMBUSTION; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXICITY; DNA DAMAGE; EFFECTOR CELL; ENVIRONMENTAL EXPOSURE; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; OSMOLARITY; OXIDATIVE STRESS; PARTICULATE MATTER; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN SECRETION; REGULATORY MECHANISM; SMOKE; SMOKING; TARGET CELL; TOBACCO; WHOLE SMOKE CONDITIONED MEDIUM; CELL CULTURE; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; IMMUNITY; IMMUNOLOGY; MONONUCLEAR CELL; SECRETION (PROCESS);

ACETYLCYSTEINE; CELLS, CULTURED; CYTOKINES; HUMANS; IMMUNITY; LEUKOCYTES, MONONUCLEAR; OXIDATIVE STRESS; T-LYMPHOCYTES, CYTOTOXIC; TOBACCO PRODUCTS;

EID: 85020109011     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-017-0602-9     Document Type: Article

References (43)

1. US Department of Health and Human Services. 2010. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease, a report of the surgeon general. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
2. Perfetti, T.A. 2011. The complexity of tobacco and tobacco smoke. Beiträge zur Tabakforschung International 24 (5): 215–232.
3. van der Vaart, H., et al. 2004. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 59 (8): 713–721.
4. Mehta, H., K. Nazzal, and R.T. Sadikot. 2008. Cigarette smoking and innate immunity. Inflammation Research 57 (11): 497–503.
5. Feng, Y., et al. 2011. Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis. Infection and Immunity 79 (1): 229–237.
6. Johnson, M.D., et al. 2009. Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco. Cancer Epidemiology, Biomarkers & Prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 18 (12): 3263–3304.
7. Fukano, Y., et al. 2004. Modified procedure of a direct in vitro exposure system for mammalian cells to whole cigarette smoke. Experimental and Toxicologic Pathology 55 (5): 317–323.
8. Arimilli, S., et al. 2012. Evaluation of cytotoxicity of different tobacco product preparations. Regulatory Toxicology and Pharmacology 64 (3): 350–360.
9. Lu, B., et al. 2007. Cytotoxicity and gene expression profiles in cell cultures exposed to whole smoke from three types of cigarettes. Toxicological Sciences 98 (2): 469–478.
10. Gao, H., G.L. Prasad, and W. Zacharias. 2013. Differential cell-specific cytotoxic responses of oral cavity cells to tobacco preparations. Toxicology In Vitro 27 (1): 282–291.
11. Ngkelo, A., et al. 2012. LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and Gia dependent PI-3kinase signalling. Journal of Inflammation 9 (1): 1–1.
12. Arimilli, S., B.E. Damratoski, and G.L. Prasad. 2013. Combustible and non-combustible tobacco product preparations differentially regulate human peripheral blood mononuclear cell functions. Toxicology in Vitro: an international journal published in association with BIBRA 27 (6): 1992–2004.
13. Chen, H., et al. 2007. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. Journal of Immunology 179 (9): 6097–6106.
14. Goncalves, R.B., et al. 2011. Impact of smoking on inflammation: overview of molecular mechanisms. Inflammation Research 60 (5): 409–424.
15. Yao, H., and I. Rahman. 2011. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. Toxicology and Applied Pharmacology 254 (2): 72–85.
16. Sundar, I.K., H. Yao, and I. Rahman. 2013. Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases. Antioxidants & Redox Signaling 18 (15): 1956–1971.
17. Hernandez, C.P., et al. 2013. Effects of cigarette smoke extract on primary activated T cells. Cellular Immunology 282 (1): 38–43.
18. Carnevali, S., et al. 2003. Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts. American Journal of Physiology-Lung Cellular and Molecular Physiology 284 (6): L955–L963.
19. De Flora, S., et al. 1995. Mechanisms of anticarcinogenesis: the example of N-acetylcysteine. In Drugs, diet and diseases. Mechanistic approach to cancer, ed. C. Ioannides and D. Lewis, 151–203. Hemel Hempstead: Horwood Ellis.
20. Groskreutz, D.J., et al. 2009. Cigarette smoke alters respiratory syncytial virus-induced apoptosis and replication. American Journal of Respiratory Cell and Molecular Biology 41 (2): 189–198.
21. Kar Mahapatra, S., et al. 2011. Alteration of immune functions and Th1/Th2 cytokine balance in nicotine-induced murine macrophages: immunomodulatory role of eugenol and N-acetylcysteine. International Immunopharmacology 11 (4): 485–495.
22. Zafarullah, M., et al. 2003. Molecular mechanisms of N-acetylcysteine actions. Cellular and Molecular Life Sciences CMLS 60 (1): 6–20.
23. De Flora, S., et al. 2001. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points. Carcinogenesis 22 (7): 999–1013.
24. Khanna, A.K., J. Xu, and M.R. Mehra. 2012. Antioxidant N-acetyl cysteine reverses cigarette smoke-induced myocardial infarction by inhibiting inflammation and oxidative stress in a rat model. Laboratory Investigation; a journal of technical methods and pathology 92 (2): 224–235.
25. Balansky, R., et al. 2010. Prevention of cigarette smoke-induced lung tumors in mice by budesonide, phenethyl isothiocyanate, and N-acetylcysteine. International Journal of Cancer 126 (5): 1047–1054.
26. Sadowska, A.M., Y.K.B. Manuel, and W.A. De Backer. 2007. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulmonary Pharmacology & Therapeutics 20 (1): 9–22.
27. Arimilli, S., et al. 2012. Rapid isolation of leukocyte subsets from fresh and cryopreserved peripheral blood mononuclear cells in clinical research. CryoLetters 33 (5): 376–384.
28. Arimilli, S., B.E. Damratoski, and L.P. G. 2015. Methods to evaluate cytotoxicity and immunosuppression of combustible tobacco product preparations. Journal of Visualized Experiments 95: 52351.
29. Kelly, G.S. 1998. Clinical applications of N-acetylcysteine. Alternative Medicine Review: a journal of clinical therapeutic 3 (2): 114–127.
30. Schmaal, L., et al. 2011. Efficacy of N-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study. European Addiction Research 17 (4): 211–216.
31. MacNee, W. 2005. Oxidants and COPD. Current Drug Targets. Inflammation and Allergy 4 (6): 627–641.
32. MacNee, W. 2005. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2 (1): 50–60.
33. Churg, A., M. Cosio, and J.L. Wright. 2008. Mechanisms of cigarette smoke-induced COPD: insights from animal models. American Journal of Physiology. Lung Cellular and Molecular Physiology 294 (4): L612–L631.
34. Puhakka, A., et al. 2003. High expression of nitric oxide synthases is a favorable prognostic sign in non-small cell lung carcinoma. APMIS 111 (12): 1137–1146.
35. Gaston, B., et al. 1994. The biology of nitrogen-oxides in the airways. American Journal of Respiratory and Critical Care Medicine 149 (2): 538–551.
36. Soini, Y., et al. 2000. Expression of inducible nitric oxide synthase in healthy pleura and in malignant mesothelioma. British Journal of Cancer 83 (7): 880–886.
37. Bowler, R.P., P.J. Barnes, and J.D. Crapo. 2004. The role of oxidative stress in chronic obstructive pulmonary disease. COPD 1 (2): 255–277.
38. Al-Shukaili, A., et al. 2009. Effect of N-acetyl-L-cysteine on cytokine production by human peripheral blood mononuclear cells. Sultan Qaboos University Medical Journal 9 (1): 70–74.
39. Asami, S., et al. 1997. Cigarette smoking induces an increase in oxidative DNA damage, 8-hydroxydeoxyguanosine, in a central site of the human lung. Carcinogenesis 18 (9): 1763–1766.
40. Albino, A.P., et al. 2004. Induction of H2AX phosphorylation in pulmonary cells by tobacco smoke: a new assay for carcinogens. Cell Cycle 3 (8): 1062–1068.
41. Mian, M.F., et al. 2008. Impairment of human NK cell cytotoxic activity and cytokine release by cigarette smoke. Journal of Leukocyte Biology 83 (3): 774–784.
42. Trapani, J.A., and M.J. Smyth. 2002. Functional significance of the perforin/granzyme cell death pathway. Nature Reviews. Immunology 2 (10): 735–747.
43. van Dommelen, S.L., et al. 2006. Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Immunity 25 (5): 835–848.